Results 231 to 240 of about 156,701 (312)

Efficacy of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1h-1,2,4-triazol-4 bromide in the rat model of inferior vena cava thrombosis

Yi Wang, Nailya Bulatova, Е. Э. Клен, G. A. Rozit, И. Л. Никитина, Л.В. Старцева, Yu. A. Bogdanova, V. S. Shchekin, А. В. Самородов   +8 more
openalex   +2 more sources

18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Imaging of Inferior Vena Cava Tumor Thrombus Extending into the Right Atrium in a Patient with Cholangiocarcinoma Treated with 90Y-Microspheres

, 2018
Luca Filippi, Annamaria Lacanfora, Roberto Cianni, Orazio Schillaci, Oreste Bagni   +4 more
openalex   +1 more source

Emestrin‐Type Epidithiodiketopiperazines Inhibited Gasdermin D‐Mediated Pyroptosis via Caspase‐3/7 Activation

MedComm, Volume 7, Issue 1, January 2026.
This study demonstrates that emestrin‐type ETPs suppress GSDMD‐mediated pyroptosis through caspase‐3/7 activation, thereby attenuating inflammatory responses and conferring protection against sepsis. In THP‐1 macrophages, ETPs significantly reduced pyroptosis and secretion of the proinflammatory cytokines IL‐1β and IL‐18.
Bingchuan Geng, Shuang Lin, Wai Yen Yim, Weiguang Sun, Xiaotian Zhang, Cao Ma, Zhiwen Zhang, Quan Guo, Jie Gao, Hanxiao Zeng, Qingyi Tong, Yixuan Wang, Zhengfeng Fan, Jincheng Hou, Muwei Li, Yonghui Zhang, Zhengxi Hu   +16 more
wiley   +1 more source

Laparoscopic Resection of a Diaphragmatic Phrenic Neurilemmoma Compressing the Suprahepatic Inferior Vena Cava Following Thoracoscopic Exploration: A Case Report. [PDF]

Surg Case Rep
Tsunematsu M, Haruki K, Hamura R, Okui N, Onda S, Sakamoto T, Taniai T, Furukawa K, Yasuda J, Ikegami T.   +9 more
europepmc   +1 more source

Prenatally Diagnosed 7q11.23 Copy Number Variations: A Retrospective Case Series

Molecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
Prenatal 7q11.23 CNVs exhibit 100% ultrasound anomalies in deletions (cardiovascular defects, growth restriction) and 50% in duplications. Inherited CNVs (50% deletions, 43% duplications) correlate with milder outcomes, while de novo variants drive high TOP rates (76.5%), emphasizing genomic testing and parental studies for precise counseling. ABSTRACT
Jiong Yan, Ziyang Liu, Song Yi, Nian Liu
wiley   +1 more source

Leiomyosarcoma of the left kidney with renal vein and inferior vena cava tumor thrombus. [PDF]

Urol Case Rep
Erickson A, Druck A, Karachristos A, Patel T.   +3 more
europepmc   +1 more source

Perforation of Inferior Vena Cava by Inferior Vena Cava Filter

, 2013
Sarah Unterman, Tad Nair
openalex   +1 more source

Using Three-Dimensional Computer Graphics for Anomalous Drainage of the Inferior Vena Cava [PDF]

Shigeto Tsuji, Yasutaka Hirata, Minoru Ōno   +2 more
openalex   +1 more source

Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task Force

Pulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise ...
Aaron B. Waxman, Abraham Babu, Roberto Badagliacca, Eloara Ferreira, Patty George, Marco Guazzi, Luke Howard, Darlene Kim, Gabor Kovacs, Saad Kubba, David Langleben, Colm McCabe, Thais Menezes, Rudolf Oliveira, Stylianos Orfanos, Inderjit Singh, David Systrom, Ryan Tedford, Rebecca Vanderpool, Carmine Dario Vizza, Franz P. Rischard   +20 more
wiley   +1 more source

Manipulation of Wnt/β‐Catenin Signaling by Synthetic Frizzled Agonist and LRP Antagonist in Organoid Cultures and In Vivo

Small Methods, Volume 10, Issue 2, 22 January 2026.
Harnessing synthetic key receptor modulators, this study presents a breakthrough in Wnt/β‐catenin regulation. The FZD agonist RRP‐pbFn bypasses LRP5/6 to drive organoid expansion and tissue regeneration, while the LRP antagonist RRP‐Dkk1c eradicates tumors. These tools enable precise pathway control, advancing regenerative and cancer therapies.
Quanhui Dai, Jiawen Wang, Zihuan Lin, Danni Yu, Hui Yang, Jinsong Wei, Xiaoyu Li, Hao Hu, Chao Ni, Bing Zhao   +9 more
wiley   +1 more source